The persisting gender gap in hypertension management and control in Germany: 1998 and 2008-2011

Hypertension Research

Volumn 39, Issue 6, 2016, Pages 457-466

  Sarganas, Giselle ^a,b   Neuhauser, Hannelore K ^a,b  

^a ROBERT KOCH INSTITUTE   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Control; Gender gap; Germany; Hypertension management; Trends

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

ADULT; AGE; AGED; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GERMANY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; REVIEW; SEX DIFFERENCE; YOUNG ADULT; ADOLESCENT; ATTITUDE TO HEALTH; DISEASE MANAGEMENT; HEALTH SURVEY; MIDDLE AGED; RISK FACTOR;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGE FACTORS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; DISEASE MANAGEMENT; FEMALE; GERMANY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS; YOUNG ADULT;

EID: 84974654776     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2016.5     Document Type: Review

References (54)

1. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvanne M, Scholte op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F, European Association for Cardiovascular Prevention and Rehabilitation (EACPR)ESC Committee for Practice Guidelines (CPG). European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012; 33: 1635-1701.
2. Vollmer WM, Sacks FM, Ard J, Appel LJ, Bray GA, Simons-Morton DG, Conlin PR, Svetkey LP, Erlinger TP, Moore TJ, Karanja N, Group DA-STCR. Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med 2001; 135: 1019-1028.
3. Elmer PJ, Obarzanek E, Vollmer WM, Simons-Morton D, Stevens VJ, Young DR, Lin PH, Champagne C, Harsha DW, Svetkey LP, Ard J, Brantley PJ, Proschan MA, Erlinger TP, Appel LJ, Group PCR. Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med 2006; 144: 485-495.
4. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338: b1665.
5. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM, American Heart Association Professional Education C. Resistant hypertension: diagnosis, evaluation, and treatment: A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008; 117: e510-e526.
6. Gu Q, Burt VL, Dillon CF, Yoon S. Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: The National Health And Nutrition Examination Survey, 2001 to 2010. Circulation 2012; 126: 2105-2114.
7. Bray EP, Holder R, Mant J, McManus RJ. Does self-monitoring reduce blood pressure? Meta-analysis with meta-regression of randomized controlled trials. Ann Med 2010; 42: 371-386.
8. Uhlig K, Patel K, Ip S, Kitsios GD, Balk EM. Self-measured blood pressure monitoring in the management of hypertension: A systematic review and meta-analysis. Ann Intern Med 2013; 159: 185-194.
9. ESH/ESC. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens 2013; 31: 1925-1938.
10. Gu Q, Burt VL, Paulose-Ram R, Dillon CF. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004. Am J Hypertens 2008; 21: 789-798.
11. Joffres MR, Ghadirian P, Fodor JG, Petrasovits A, Chockalingam A, Hamet P. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens 1997; 10 (10 Pt 1): 1097-1102.
12. Neuhauser HK, Adler C, Rosario AS, Diederichs C, Ellert U. Hypertension prevalence, awareness, treatment and control in Germany 1998 and 2008-11. J Hum Hypertens 2015; 29: 247-253.
13. Primatesta P, Poulter NR. Improvement in hypertension management in England: results from the Health Survey for England 2003. J Hypertens 2006; 24: 1187-1192.
14. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, Poulter N, Primatesta P, Stegmayr B, Thamm M. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004; 43: 10-17.
15. Onysko J, Maxwell C, Eliasziw M, Zhang JX, Johansen H, Campbell NR, Canadian Hypertension Education Program. Large increases in hypertension diagnosis and treatment in Canada after a healthcare professional education program. Hypertension 2006; 48: 853-860.
16. Falaschetti E, Mindell J, Knott C, Poulter N. Hypertension management in England: A serial cross-sectional study from 1994 to 2011. Lancet 2014; 383: 1912-1919.
17. Sarganas G, Knopf H, Grams D, Neuhauser HK. Trends in antihypertensive medication use and blood pressure control among adults with hypertension in Germany. Am J Hypertens 2015; 29: 104-113.
18. Thefeld W, Stolzenberg H, Bellach BM. The Federal Health Survey: response, composition of participants and non-responder analysis. Gesundheitswesen 1999; 61 Spec No, S57-S61.
19. Scheidt-Nave C, Kamtsiuris P, Gosswald A, Holling H, Lange M, Busch MA, Dahm S, Dolle R, Ellert U, Fuchs J, Hapke U, Heidemann C, Knopf H, Laussmann D, Mensink GB, Neuhauser H, Richter A, Sass AC, Rosario AS, Stolzenberg H, Thamm M, Kurth BM. German health interview and examination survey for adults (DEGS)-design, objectives and implementation of the first data collection wave. BMC Public Health 2012; 12: 730.
20. Neuhauser HK, Ellert U, Thamm M, Adler C. Calibration of blood pressure data after replacement of the standard mercury sphygmomanometer by an oscillometric device and concurrent change of cuffs. Blood Press Monit 2014; 20: 39-42.
21. Knopf H, Grams D. Medication use of adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013; 56: 868-877.
22. Lampert T, Kroll L, Muters S, Stolzenberg H. Measurement of socioeconomic status in the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013; 56: 631-636.
23. Dybek I, Bischof G, Grothues J, Reinhardt S, Meyer C, Hapke U, John U, Broocks A, Hohagen F, Rumpf HJ. The reliability and validity of the Alcohol Use Disorders Identification Test (AUDIT) in a German general practice population sample. J Stud Alcohol 2006; 67: 473-481.
24. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): An effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med 1998; 158: 1789-1795.
25. Krug S, Jordan S, Mensink GB, Muters S, Finger J, Lampert T. Physical activity: results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013; 56: 765-771.
26. Falaschetti E, Chaudhury M, Mindell J, Poulter N. Continued improvement in hypertension management in England: results from the Health Survey for England 2006. Hypertension 2009; 53: 480-486.
27. Gee ME, Bienek A, McAlister FA, Robitaille C, Joffres M, Tremblay MS, Johansen H, Campbell NR. Factors associated with lack of awareness and uncontrolled high blood pressure among Canadian adults with hypertension. Can J Cardiol 2012; 28: 375-382.
28. Everett B, Zajacova A. Gender differences in hypertension and hypertension awareness among young adults. Biodemography Soc Biol 2015; 61: 1-17.
29. Godet-Mardirossian H, Girerd X, Vernay M, Chamontin B, Castetbon K, de Peretti C. Patterns of hypertension management in France (ENNS 2006-2007). Eur J Prev Cardiol 2012; 19: 213-220.
30. Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012. NCHS Data Brief 2013; 133: 1-8.
31. Gee ME, Campbell NR, Gwadry-Sridhar F, Nolan RP, Kaczorowski J, Bienek A, Robitaille C, Joffres M, Dai S, Walker RL, Outcomes Research Task Force of the Canadian Hypertension Education Program. Antihypertensive medication use, adherence, stops, and starts in Canadians with hypertension. Can J Cardiol 2012; 28: 383-389.
32. Turnbull F, Woodward M, Neal B, Barzi F, Ninomiya T, Chalmers J, Perkovic V, Li N, MacMahon S, Blood Pressure Lowering Treatment Trialists Collaboration. Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. Eur Heart J 2008; 29: 2669-2680.
33. Matsui K, Kim-Mitsuyama S, Ogawa H, Jinnouchi T, Jinnouchi H, Arakawa K, OlmeSartan Calcium Antagonists Randomized Study Group. Sex differences in response to angiotensin II receptor blocker-based therapy in elderly, high-risk, hypertensive Japanese patients: A subanalysis of the OSCAR study. Hypertens Res 2014; 37: 526-532.
34. Safar ME, Myers MG, Leenen F, Asmar R. Gender influence on the dose-ranging of a low-dose perindopril-indapamide combination in hypertension: effect on systolic and pulse pressure. J Hypertens 2002; 20: 1653-1661.
35. Boggia J, Thijs L, Hansen TW, Li Y, Kikuya M, Bjorklund-Bodegard K, Richart T, Ohkubo T, Jeppesen J, Torp-Pedersen C, Dolan E, Kuznetsova T, Olszanecka A, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Maestre G, Sandoya E, Kawecka-Jaszcz K, Imai Y, Wang J, Ibsen H, O'Brien E, Staessen JA, International Database on Ambulatory blood pressure in relation to Cardiovascular Outcomes Investigations. Ambulatory blood pressure monitoring in 9357 subjects from 11 populations highlights missed opportunities for cardiovascular prevention in women. Hypertension 2011; 57: 397-405.
36. Klungel OH, de Boer A, Paes AH, Seidell JC, Bakker A. Sex differences in antihypertensive drug use: determinants of the choice of medication for hypertension. J Hypertens 1998; 16: 1545-1553.
37. Ljungman C, Kahan T, Schioler L, Hjerpe P, Hasselstrom J, Wettermark B, Bostrom KB, Manhem K. Gender differences in antihypertensive drug treatment: results from the Swedish Primary Care Cardiovascular Database (SPCCD). J Am Soc Hypertens 2014; 8: 882-890.
38. Keyhani S, Scobie JV, Hebert PL, McLaughlin MA. Gender disparities in blood pressure control and cardiovascular care in a national sample of ambulatory care visits. Hypertension 2008; 51: 1149-1155.
39. Carlsson AC, Wandell P, Sundquist K, Johansson SE, Sundquist J. Effects of prescribed antihypertensives and other cardiovascular drugs on mortality in patients with atrial fibrillation and hypertension: A cohort study from Sweden. Hypertens Res 2014; 37: 553-559.
40. Visser LE, Stricker BH, van der Velden J, Paes AH, Bakker A. Angiotensin converting enzyme inhibitor associated cough: A population-based case-control study. J Clin Epidemiol 1995; 48: 851-857.
41. al Khaja KA, Sequeira RP, al Damanhori AH, Mathur VS. Antihypertensive drugassociated sexual dysfunction: A prescription analysis-based study. Pharmacoepidemiol Drug Saf 2003; 12: 203-212.
42. La Torre A, Giupponi G, Duffy D, Conca A, Catanzariti D. Sexual dysfunction related to drugs: A critical review. Part IV: cardiovascular drugs. Pharmacopsychiatry 2015; 48: 1-6.
43. Thoenes M, Neuberger HR, Volpe M, Khan BV, Kirch W, Bohm M. Antihypertensive drug therapy and blood pressure control in men and women: An international perspective. J Hum Hypertens 2010; 24: 336-344.
44. Barrios V, Escobar C, Calderon A, Llisterri JL, Echarri R, Alegria E, Muniz J, Matali A. Blood pressure and lipid goal attainment in the hypertensive population in the primary care setting in Spain. J Clin Hypertens 2007; 9: 324-329.
45. Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA 2005; 294: 466-472.
46. Wilkins K, Gee M, Campbell N. The difference in hypertension control between older men and women. Health Rep 2012; 23: 33-40.
47. Daugherty SL, Masoudi FA, Ellis JL, Ho PM, Schmittdiel JA, Tavel HM, Selby JV, O'Connor PJ, Margolis KL, Magid DJ. Age-dependent gender differences in hypertension management. J Hypertens 2011; 29: 1005-1011.
48. Christe V, Waeber G, Vollenweider P, Marques-Vidal P. Antihypertensive drug treatment changes in the general population: The CoLaus study. BMC Pharmacol Toxicol 2014; 15: 20.
49. Lumley B, Waterall J, Kearney M, Fenton KA. Tackling high blood pressure in England: A new approach. J Clin Hypertens 2015; 17: 575-577.
50. Bancej CM, Campbell N, McKay DW, Nichol M, Walker RL, Kaczorowski J. Home blood pressure monitoring among Canadian adults with hypertension: results from the 2009 Survey on Living with Chronic Diseases in Canada. Can J Cardiol 2010; 26: e152-e157.
51. Wagner A, Sadoun A, Dallongeville J, Ferrieres J, Amouyel P, Ruidavets JB, Arveiler D. High blood pressure prevalence and control in a middle-aged French population and their associated factors: The MONA LISA study. J Hypertens 2011; 29: 43-50.
52. Chu SH, Baek JW, Kim ES, Stefani KM, Lee WJ, Park YR, Youm Y, Kim HC. Gender differences in hypertension control among older korean adults: Korean social life, health, and aging project. J Prev Med Public Health 2015; 48: 38-47.
53. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr., Jones DW, Materson BJ, Oparil S, Wright JT Jr., Roccella EJ, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute, National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
54. Kamtsiuris P, Lange M, Hoffmann R, Schaffrath Rosario A, Dahm S, Kuhnert R, Kurth BM. The first wave of the German Health Interview and Examination Survey for Adults (DEGS1): sample design, response, weighting and representativeness. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013; 56: 620-630.